Abbott's ABT diversified business portfolio is well-positioned to drive momentum. However, the international business environment continues to be challenging globally. The stock carries a Zacks Rank ...

This included growth of 27% in the United States. Within Abbott’s Established Pharmaceuticals Division (EPD) business, the company is also strategically progressing with its advancement in ...